These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 791738)
1. [Cultural, biochemical, cytochemical, pathogenic and morphological aspects (as seen with the scanning microscope) of pathogenic strains of Candida albicans treated with pyrrolnitrin]. Costa AL G Batteriol Virol Immunol; 1975; 68(7-12):247-69. PubMed ID: 791738 [TBL] [Abstract][Full Text] [Related]
2. Release of surface antigens of Candida albicans after treatment with pyrrolnitrin. Misefari A; Costa G; Costa AL; Valenti A Farmaco Prat; 1979 Jan; 34(1):42-5. PubMed ID: 378688 [No Abstract] [Full Text] [Related]
3. [Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin A]. Corelli F; Massa S; Stefancich G; Mai A; Artico M; Panico S; Simonetti N Farmaco Sci; 1987 Dec; 42(12):893-903. PubMed ID: 3329612 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of fluconazole on Candida albicans. Abecia LC; Arévalo JM; López MJ Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696 [TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal activity of N-3-(1,2,4-dithiazole-5-thione)-beta-resorcylcarbothioamide. Niewiadomy A; Krajewska-Kułak E; Lukaszuk C; Matysiak J; Kostecka M Rocz Akad Med Bialymst; 2005; 50 Suppl 1():31-5. PubMed ID: 16119621 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Candida infection. II. Application of biochemical methods for typing of Candida albicans strains. Budak A Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):369-77. PubMed ID: 2130802 [TBL] [Abstract][Full Text] [Related]
7. In vitro antifungal activity of 2,5 disubstituted amino-oksometyloso-arylo-thiadiazole derivatives. Lukaszuk C; Krajewska-Kułak E; Niewiadomy A; Stachowicz J; Głaszcz U; Oksiejczuk E Adv Med Sci; 2007; 52 Suppl 1():26-9. PubMed ID: 18229628 [TBL] [Abstract][Full Text] [Related]
8. Adansonian study of Candida albicans: intraspecific homogeneity excepting C. stellatoidea strains. Kamiyama A; Niimi M; Tokunaga M; Nakayama H J Med Vet Mycol; 1989; 27(4):229-41. PubMed ID: 2677300 [TBL] [Abstract][Full Text] [Related]
9. Respiratory deficiency enhances the sensitivity of the pathogenic fungus Candida to photodynamic treatment. Chabrier-Roselló Y; Foster TH; Mitra S; Haidaris CG Photochem Photobiol; 2008; 84(5):1141-8. PubMed ID: 18248505 [TBL] [Abstract][Full Text] [Related]
10. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole]. Kurnatowski P; Makieło L; Horwatt-Bozyczko E Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440 [TBL] [Abstract][Full Text] [Related]
11. The Candida albicans Ddr48 protein is essential for filamentation, stress response, and confers partial antifungal drug resistance. Dib L; Hayek P; Sadek H; Beyrouthy B; Khalaf RA Med Sci Monit; 2008 Jun; 14(6):BR113-121. PubMed ID: 18509269 [TBL] [Abstract][Full Text] [Related]
12. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Braga PC; Culici M; Alfieri M; Dal Sasso M Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858 [TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis. Liu XP; Fan SR; Bai FY; Li J; Liao QP Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300 [TBL] [Abstract][Full Text] [Related]
14. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study. Małafiej E; Adamiec AC; Tworzyańska U Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468 [TBL] [Abstract][Full Text] [Related]
15. [Activity of the azole drugs in vitro against strains of Candida albicans with different codes isolated from the digestive tract in children]. Kurnatowski M; Kurnatowska A; Wasowska-Królikowska K Wiad Parazytol; 2004; 50(3):387-92. PubMed ID: 16865942 [TBL] [Abstract][Full Text] [Related]
16. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans]. Costa AL; Valenti A; Costa G; Calogero F G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772 [TBL] [Abstract][Full Text] [Related]
17. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole]. Yücesoy M; Marol S Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666 [TBL] [Abstract][Full Text] [Related]
18. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. Navarathna DH; Hornby JM; Hoerrmann N; Parkhurst AM; Duhamel GE; Nickerson KW J Antimicrob Chemother; 2005 Dec; 56(6):1156-9. PubMed ID: 16239285 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients. Paniagua GL; Monroy E; Negrete E; Vaca S Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773 [TBL] [Abstract][Full Text] [Related]
20. High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione. Gyetvai A; Emri T; Fekete A; Varga Z; Gazdag Z; Pesti M; Belágyi J; Emõdy L; Pócsi I; Lenkey B FEMS Yeast Res; 2007 Mar; 7(2):265-75. PubMed ID: 17266730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]